Synopsis
Synopsis
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
FDF
0
FDA Orange Book
0
Europe
0
Australia
0
South Africa
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. Apramycin
2. Ebl-1003
1. 65710-07-8
2. Apramycin Sulphate
3. Apramycin (sulfate)
4. 8uyl6naz3q
5. Ai3-29795
6. 410097-64-2
7. Apramycin Sulfate Salt
8. (2r,3r,4s,5s,6s)-2-[[(2r,3s,4r,4ar,6s,7r,8as)-7-amino-6-[(1r,2r,3s,4r,6s)-4,6-diamino-2,3-dihydroxycyclohexyl]oxy-4-hydroxy-3-(methylamino)-2,3,4,4a,6,7,8,8a-octahydropyrano[3,2-b]pyran-2-yl]oxy]-5-amino-6-(hydroxymethyl)oxane-3,4-diol Sulfuric Acid
9. (2r,3r,4s,5s,6s)-2-[[(2r,3s,4r,4ar,6s,7r,8as)-7-amino-6-[(1r,2r,3s,4r,6s)-4,6-diamino-2,3-dihydroxycyclohexyl]oxy-4-hydroxy-3-(methylamino)-2,3,4,4a,6,7,8,8a-octahydropyrano[3,2-b]pyran-2-yl]oxy]-5-amino-6-(hydroxymethyl)oxane-3,4-diol;sulfuric Acid
10. (2r,3r,4s,5s,6s)-5-amino-2-(((2r,3s,4r,4ar,6s,7r,8as)-7-amino-6-(((1r,2r,3s,4r,6s)-4,6-diamino-2,3-dihydroxycyclohexyl)oxy)-4-hydroxy-3-(methylamino)octahydropyrano[3,2-b]pyran-2-yl)oxy)-6-(hydroxymethyl)tetrahydro-2h-pyran-3,4-diol Sulfate
11. Ino-6-(hydroxymethyl)oxane-3,4-diol;sulfuric Acid
12. Unii-8uyl6naz3q
13. (2r,3r,4s,5s,6s)-2-[[(2r,3s,4r,4ar,6s,7r,8as)-7-amino-6-[(1r,2r,3s,4r,6s)-4,6-diamino-2,3-dihydroxycyclohexyl]oxy-4-hydroxy-3-(methylamino)-2,3,4,4a,6,7,8,8a-octahydropyrano[3,2-b]pyran-2-yl]oxy]-5-am
14. Einecs 265-890-7
15. Apramycin, Sulfate (2:5)
16. Schembl94999
17. (+)-apramycin Sulfate
18. Apramycin Sulfate [mart.]
19. Chebi:190734
20. Hy-b1329
21. Mfcd06200257
22. S4254
23. Akos016010323
24. Apramycin Sulfate [green Book]
25. Ccg-270308
26. Cs-4854
27. Apramycin Sulfate Salt, >=95% (tlc)
28. As-35223
29. 710a078
30. A923667
31. W-104790
32. Apramycin Sulfate, Antibiotic For Culture Media Use Only
33. (2r,3r,4s,5s,6s)-2-[[(2r,3s,4r,4ar,6s,7r,8as)-7-amino-6-[(1r,2r,3s,4r,6s)-4,6-diamino-2,3-dihydroxycyclohexyl]oxy-4-hydroxy-3-(methylamino)-2,3,4,4a,6,7,8,8a-octahydropyrano[3,2-b]pyran-2-yl]oxy]-5-amino-6-(hydroxymethyl)oxane-3,4-diol;suluric Acid
34. (2r,3r,4s,5s,6s)-5-amino-2-(((2r,3s,4r,4ar,6s,7r,8as)-7-amino-6-(((1r,2r,3s,4r,6s)-4,6-diamino-2,3-dihydroxycyclohexyl)oxy)-4-hydroxy-3-(methylamino)octahydropyrano[3,2-b]pyran-2-yl)oxy)-6-(hydroxymethyl)tetrahydro-2h-pyran-3,4-diol Xsulfate
35. (2r,3r,4s,5s,6s)-5-amino-2-(((2r,3s,4r,4ar,6s,7r,8as)-7-amino-6-(((1r,2r,3s,4r,6s)-4,6-diamino-2,3-dihydroxycyclohexyl)oxy)-4-hydroxy-3-(methylamino)octahydropyrano[3,2-b]pyran-2-yl)oxy)-6-(hydroxymethyl)tetrahydro-2h-pyran-3,4-diolxsulfate
36. D-streptamine, O-4-amino-4-deoxy-.alpha.-d-glucopyranosyl-(1-8)-o-(8r)-2-amino-2,3,7-trideoxy-7-(methylamino)-d-glycero-.alpha.-d-allo-octodialdo-1,5:8,4-dipyranosyl-(1-4)-2-deoxy-, Sulfate
37. D-streptamine, O-4-amino-4-deoxy-alpha-d-glucopyranosyl-(1-8)-o-(8r)-2-amino-2,3,7-trideoxy-7-(methylamino)-d-glycero-alpha-d-allo-octadialdo-1,5:8,4-dipyranosyl-(1-4)-2-deoxy-, Sulfate (salt)
| Molecular Weight | 637.7 g/mol |
|---|---|
| Molecular Formula | C21H43N5O15S |
| Hydrogen Bond Donor Count | 13 |
| Hydrogen Bond Acceptor Count | 20 |
| Rotatable Bond Count | 6 |
| Exact Mass | 637.24763686 g/mol |
| Monoisotopic Mass | 637.24763686 g/mol |
| Topological Polar Surface Area | 367 Ų |
| Heavy Atom Count | 42 |
| Formal Charge | 0 |
| Complexity | 841 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 17 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 2 |
Anti-Bacterial Agents
Substances that inhibit the growth or reproduction of BACTERIA. (See all compounds classified as Anti-Bacterial Agents.)
FDF Dossiers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Market Place
ABOUT THIS PAGE
A Apramycin Sulfate manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Apramycin Sulfate, including repackagers and relabelers. The FDA regulates Apramycin Sulfate manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Apramycin Sulfate API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Apramycin Sulfate manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Apramycin Sulfate supplier is an individual or a company that provides Apramycin Sulfate active pharmaceutical ingredient (API) or Apramycin Sulfate finished formulations upon request. The Apramycin Sulfate suppliers may include Apramycin Sulfate API manufacturers, exporters, distributors and traders.
click here to find a list of Apramycin Sulfate suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
Apramycin Sulfate Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Apramycin Sulfate GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Apramycin Sulfate GMP manufacturer or Apramycin Sulfate GMP API supplier for your needs.
A Apramycin Sulfate CoA (Certificate of Analysis) is a formal document that attests to Apramycin Sulfate's compliance with Apramycin Sulfate specifications and serves as a tool for batch-level quality control.
Apramycin Sulfate CoA mostly includes findings from lab analyses of a specific batch. For each Apramycin Sulfate CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Apramycin Sulfate may be tested according to a variety of international standards, such as European Pharmacopoeia (Apramycin Sulfate EP), Apramycin Sulfate JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Apramycin Sulfate USP).
LOOKING FOR A SUPPLIER?
